Novo Nordisk CEO explains decision to discontinue the long-acting insulin Levemir. He blamed pharmacy managers and health ...

The prevalence of diabetes in the United States increased by 18.6% from 2012 to 2022, with notably higher rates among racial ...

While several factors predict sustained glycemic control, predictors of sustained weight control with tirzepatide appear ...

During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced toug ...

Staying vigilant and addressing these subtle symptoms early can go a long way in managing diabetic nephropathy and ensuring ...

Living with diabetes comes with many challenges, but one of the most pressing concerns is the increased risk of stroke.

Minnesota clinics are starting to receive free or low-cost insulin from Eli Lilly and Sanofi. This comes after the Minnesota ...

BPGbio, a pioneering biology-first, AI-powered, clinical-stage biopharma specializing in mitochondrial biology and protein homeostasis, and Joslin Diabetes Center, the world's leading diabetes care ...

MUSIC helped bring harmony to Hugh Mather’s medical career, and the consultant shared his passion every Friday lunchtime by organising ...

While Congress debates the high cost of brand-name diabetes and weight loss drugs, Atlanta doctors are selling lower-cost alternatives made by compounding pharmacies.

For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...

An expert from Cigna Healthcare explains why, along with individualized offerings, budget and communication plans are vital ...